Delivery Order SPE2DB22D3301-SPE2DB25FX4QS
Award Date
10/29/24
Potential Completion Date
11/20/24
Potential Value
$9.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Pfizer COVID-19 vaccines for the 2024-2025 time period. The award, valued at $1,092.06, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the vendor Amerisourcebergen Drug Corp, Corporate Office Division. The $1,135.77 Firm Fixed Price contract is for the delivery of Pfizer COVID vaccines in 0.9 mL doses for the 2024-2025 period, with an ultimate completion date of September 26, 2024. The award was made as a Delivery Order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,271.56 firm fixed-price delivery order is for the supply of 0.9 mL Pfizer COVID-19 vaccines for the 2024-2025 timeframe, under an Expanded Use Authorization (EUA). The contract has an ultimate completion date of November 15, 2024 and was awarded on October 24, 2024. Amerisourcebergen holds a significant...
This federal contract award, valued at $1,100.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Pfizer COVID-19 vaccines from 2024 to 2025. The contract is a Firm Fixed Price Delivery Order with a completion date of May 21, 2025. This award is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued at $999,999,999.00, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,100.15 Firm Fixed Price delivery order is for the supply of Pfizer COVID-19 vaccines and related medical products from 2024 to 2025, with a potential performance period of up to 4 years. The contract is not set aside and was openly competed. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This federal contract award is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,100.15, is for the procurement of Pfizer COVID-19 vaccine doses for the 2024-2025 time period, with an ultimate completion date of April 24, 2025. The contract is a firm-fixed-price arrangement and does not have a set-aside designation. AmerisourceBergen Drug Corp holds a...
This federal contract award is for the delivery of 0.9mL COVID-19 vaccines from Pfizer to the Defense Logistics Agency (DLA) from September 2024 through September 2025. The contract, valued at $1,135.77, is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. There was no set-aside used for this award. This contract is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical...
This federal contract award, valued at $6,600.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,129.80, is a Firm Fixed Price Delivery Order for the procurement of Pfizer COVID-19 vaccine doses for the 2024-2025 period, including an emergency use authorization (EUA) 0.9 ML product. The contract has an ultimate completion date of March 6, 2025 and was awarded on February 12, 2025. This...
This federal contract award is a Delivery Order valued at $5,460.30 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Pfizer COVID-19 vaccines for the 2024-2025 timeframe, with an ultimate completion date of December 9, 2024. This award is not associated with a set-aside designation, indicating open competition. The contract is a Firm Fixed Price arrangement,...